Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.593 USD | -8.91% | -21.27% | +73.57% |
09/05 | Monopar Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
16/04 | Monopar Therapeutics Files Provisional Patent for New MNPR-101 Construct | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+73.57% | 1.14Cr | |
+29.32% | 4.92TCr | |
+0.99% | 4.21TCr | |
+50.47% | 4.04TCr | |
-5.26% | 2.89TCr | |
+13.64% | 2.61TCr | |
-22.72% | 1.87TCr | |
+8.42% | 1.33TCr | |
+32.20% | 1.23TCr | |
-0.74% | 1.2TCr |
- Stock Market
- Equities
- MNPR Stock
- News Monopar Therapeutics Inc.
- Monopar Therapeutics, National University of Singapore Enter Cancer Research Collaboration